EUVIMEDEUVIMED entdecken
Open Access

Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort

Rehan R Syed iD, Donald G Catanzaro iD, Rebecca E Colman iD, Christopher G Cooney, Yvonne Linger, Alexander V Kukhtin, Rebecca C Holmberg, Ryan Norville, Valeriu Crudu, Nelly Ciobanu, Alexandru Codreanu, Marva Seifert iD und 4 weitere

Journal of Clinical Microbiology · 2023

DOI: 10.1128/jcm.01478-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2023. Verfasst von Rehan R Syed und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California, San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While the goal of universal drug susceptibility testing has been a key component of the WHO End TB Strategy, in practice, this remains inaccessible to many. Rapid molecular tests for tuberculosis (TB) and antituberculosis drug resistance could significantly improve access to testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisHumansKanamycinIsoniazidCapreomycinAmikacinRifampinFluoroquinolonesMicrobial Sensitivity TestsProspective StudiesBacterial ProteinsDrug Resistance, Multiple, BacterialAntitubercular Agents

Stichwörter der Autor:innen

Mycobacterium tuberculosisamikacincapreomycindrug susceptibilitydrug-resistant tuberculosisfluoroquinoloneisoniazidkanamycinlateral-flow cellrifampin

Substanzen

KanamycinIsoniazidCapreomycinAmikacinRifampinFluoroquinolonesBacterial ProteinsAntitubercular Agents

Autor:innen und Institutionen

  • Department of Medicine, University of California, San Diego, La Jolla, California, USA.
  • Department of Biological Sciences, University of Arkansas, Fayetteville, Arkansas, USA.
  • Akonni Biosystems, Inc., Frederick, Maryland, USA.
  • Phthisiopneumology Institute, Chișinău, Republic of Moldova.
  • Herbert Wertheim School of Public Health and Human Longevity Science, University of California, San Diego, La Jolla, California, USA.

ORCID-Profile: Rehan R Syed, Donald G Catanzaro, Rebecca E Colman, Marva Seifert

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • NIGMS NIH HHS
  • NIBIB NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases
  • HHS | NIH | National Institute of Biomedical Imaging and Bioengineering
  • HHS | NIH | National Institute of General Medical Sciences

Zitieren

APA

Syed, R. R., Catanzaro, D. G., Colman, R. E., Cooney, C. G., Linger, Y., Kukhtin, A. V., Holmberg, R. C., Norville, R., Crudu, V., Ciobanu, N., Codreanu, A., Seifert, M., Hillery, N., Chiles, P., Catanzaro, A., & Rodwell, T. C. (2023). Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01478-22

Vancouver

Syed RR, Catanzaro DG, Colman RE, Cooney CG, Linger Y, Kukhtin AV, et al. Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort. Journal of Clinical Microbiology. 2023. doi:10.1128/jcm.01478-22

BibTeX
@article{Syed2023,
  author = {Syed, Rehan R and Catanzaro, Donald G and Colman, Rebecca E and Cooney, Christopher G and Linger, Yvonne and Kukhtin, Alexander V and Holmberg, Rebecca C and Norville, Ryan and Crudu, Valeriu and Ciobanu, Nelly and Codreanu, Alexandru and Seifert, Marva and Hillery, Naomi and Chiles, Peter and Catanzaro, Antonino and Rodwell, Timothy C},
  title = {Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort},
  journal = {Journal of Clinical Microbiology},
  year = {2023},
  doi = {10.1128/jcm.01478-22}
}
Kostenlos starten →